Multiple MyelomaPeripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationHematopoietic Stem CellsStem Cell TransplantationMelphalanLeukapheresisGranulocyte Colony-Stimulating FactorTransplantation, HomologousCord Blood Stem Cell TransplantationBlood Component RemovalMyeloma ProteinsAntigens, CD34Boronic AcidsPyrazinesTransplantation ConditioningThalidomideEmbryonic Stem CellsHematologic NeoplasmsAdult Stem CellsPlasma CellsGraft vs Host DiseaseCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideBone Marrow TransplantationPluripotent Stem CellsParaproteinemiasGraft SurvivalBone MarrowTreatment OutcomeStem Cell NicheCell DifferentiationAntineoplastic Agents, AlkylatingBusulfanDexamethasoneNeural Stem CellsBone Marrow CellsBlood CellsInduced Pluripotent Stem CellsRemission InductionHematopoiesisRecurrenceBlood Cell CountStem Cell FactorMonoclonal Gammopathy of Undetermined SignificanceLymphoma, Non-HodgkinMultipotent Stem CellsMesenchymal Stem Cell TransplantationFetal BloodMyeloablative AgonistsLeukemia, Plasma CellMesenchymal Stromal CellsAntineoplastic AgentsPlasmacytomaVincristineFlow CytometryCell LineageThiotepaWhole-Body IrradiationEtoposideTissue DonorsDisease-Free SurvivalMice, SCIDSalvage TherapyLeukemiaSurvival RateCell ProliferationCell SeparationTransplantation ChimeraSyndecan-1Survival AnalysisAmyloidosisColony-Forming Units AssayDoxorubicinTime FactorsCells, CulturedCell Line, TumorBone Marrow PurgingHistocompatibilityRetrospective StudiesLymphomaInfectionImmunophenotypingAntigens, CDPrednisonePlatelet CountStem Cell ResearchHistocompatibility TestingRecombinant ProteinsPOEMS SyndromeVidarabineHematologic DiseasesNeoplastic Stem CellsNeoplasmsPrognosisPlant Stems